MARKET NEWS

Entera Bio Reports Positive Results from a Phase 2 PK/PD Study of Oral PTH
Atlas Nanotech Announces Successful Development of First-Ever OTC Nanotechnology Vitamin A
Mustang Bio Announces Phase 1 Clinical Trial
Novo Nordisk & Emisphere Announce Development Update
Minerva Neurosciences & Catalent Enter Commercial Supply Agreement
Aptevo Therapeutics Introduces New Adaptir Bispecific Antibody Candidate

  FEATURED EDITORIAL

  COMPANY PROFILE

The Sonceboz drug delivery device platform is designed for maximum flexibility for pharmaceutical companies with the goal to cover the full lifespan of a drug product starting from clinical trials to later lifecycle management activities. This is achieved by ensuring that existing fill and finish processes, primary containers and materials can be integrated seamlessly. Reduction of risk is one of the most important goals for pharmaceutical companies and by multiplying a device solution for different use-cases serves this purpose since the technology is established and well understood. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Dance Biopharm Presents Phase 2 Clinical Data Highlighting Rapid Effects of Inhaled Human Insulin

Dance Biopharm Presents Phase 2 Clinical Data Highlighting Rapid Effects of Inhaled Human Insulin

Dance Biopharm Holdings, Inc., recently presented data from its Phase 2 clinical study of Dance 501, a novel gentle mist formulation of human insulin administered with its….

Immutep to Receive Milestone Payment From GSK

Immutep to Receive Milestone Payment From GSK

Immutep Limited recently announced it will receive a milestone payment from GSK of $5.02 million related to the first patient being dosed in…..

Novel Small Molecule Drug Discovery Platform Harnesses Immune System to  Defeat Cancers, Viral Infections & Inflammatory Diseases

Novel Small Molecule Drug Discovery Platform Harnesses Immune System to Defeat Cancers, Viral Infections & Inflammatory Diseases

Now, the power of nucleic acid technology is being harnessed to design small molecule nucleic acid hybrid (SMNH) drugs that harness the patient’s own immune system to defeat…..

2019 Analytical Testing in Drug Development eBook - Regulations Help Propel Testing Market

2019 Analytical Testing in Drug Development eBook - Regulations Help Propel Testing Market

This e-Book showcases the various types of services that leading testing companies offer and how they are helping industry comply with regulations to get their products approved and commercialized.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 9 – API Synthesis
October 16 – Bioavailability